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Abstract
Prion diseases are a family of unique fatal transmissible neurodegenerative diseases that affect humans and many animals.
Sporadic Creutzfeldt-Jakob disease (sCJD) is the most common prion disease in humans, accounting for 85–90% of all
human prion cases, and exhibits a high degree of diversity in phenotypes. The etiology of sCJD remains to be elucidated.
The human prion protein gene has an octapeptide repeat region (octarepeats) that normally contains 5 repeats of 24–27 bp
(1 nonapeptide and 4 octapeptide coding sequences). An increase of the octarepeat numbers to six or more or a decrease
of the octarepeat number to three is linked to genetic prion diseases with heterogeneous phenotypes in humans. Here we
report that the human octarepeat region is prone to either contraction or expansion when subjected to PCR amplification in
vitro using Taq or Pwo polymerase and when replicated in wild type E. coli cells. Octarepeat insertion mutants were even
less stable, and the mutation rate for the wild type octarepeats was much higher when replicated in DNA mismatch repair-
deficient E.coli cells. All observed octarepeat mutants resulting from DNA replication in E.coli were contained in head-to-
head plasmid dimers and DNA mfold analysis (http://mfold.rna.albany.edu/?q=mfold/DNA-Folding-Form) indicates that
both DNA strands of the octarepeat region would likely form multiple stable hairpin structures, suggesting that the
octarepeat sequence may form stable hairpin structures during DNA replication or repair to cause octarepeat instability.
These results provide the first evidence supporting a somatic octarepeat mutation-based model for human sCJD etiology: 1)
the instability of the octarepeat region leads to accumulation of somatic octarepeat mutations in brain cells during
development and aging, 2) this instability is augmented by compromised DNA mismatch repair in aged cells, and 3)
eventually some of the octarepeat mutation-containing brain cells start spontaneous de novo prion formation and
replication to initiate sCJD.
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Introduction
Prion diseases, or transmissible spongiform encephalopathies
(TSEs), are a unique family of fatal neurodegenerative diseases
that affect both humans and animals. Prion replication requires
the conformational conversion of the cellular prion protein (PrP
C)
from an alpha-helical conformer to beta-sheet rich disease-
associated aggregates (PrP
Sc). Human prion diseases include
Creutzfeldt-Jakob disease (CJD), fatal insomnia, Gerstmann-
Stra ¨ussler-Scheinker disease (GSS), Kuru, and the newly identified
variably protease-sensitive prionopathy (VPSPr) [1,2]. Human
prion diseases can be grouped into three classes based on etiology:
familial (genetic), sporadic, and acquired (infectious), among which
sporadic CJD (sCJD) is the most common, accounting for 85–90%
of all human prion cases with very diverse phenotypes. However,
practically nothing is known about the mechanisms underlying the
development of sCJD.
The human prion protein (PrP) is encoded by the PRNP gene, a
single copy gene on chromosome 20. A large number of point
mutations in the PRNP coding region have been linked to inherited
prion diseases with diverse phenotypes: familial CJD (fCJD), GSS,
fatal familial insomnia (FFI), and mixed phenotypes [1]. The most
common PRNP point mutations include E200K (fCJD), P102L
(GSS), D178N-129M (FFI), and D178N-129V (fCJD) [1]. In
addition, PRNP has an octarepeat region (R1-R2-R2-R3-R4), of
which the R1 repeat encodes a nonapeptide (PQGGGGWGQ)
and the other four repeats all encode octapeptides (PHGGGW-
GQ) (Figure 1A). Insertion mutations with 1–9 extra octarepeats
or deletion mutations with loss of two octarepeats also cause
familial prion diseases, in which the clinical and pathological
phenotypes are heterogeneous and heavily influenced by the
number of octarepeats [1]. Some of the insertion mutants contain
novel variant repeats (Figure 1A) that may have resulted from
recombination between wild type repeats [3]. These pathogenic
PRNP mutations are believed to cause prion diseases by rendering
the corresponding mutant PrP protein more prone to adopting a
prion-associated conformation [4,5].
Somatic mutations of specific gene(s) have been reported to be
critical for the development of cancer [6,7] and neurodegenerative
diseases such as Huntington’s disease [8–10] and Alzheimer’s
disease [11]. In Huntington’s disease patients, the CAG repeats of
the huntingtin gene expand in an age-dependent manner in brain
tissues [12], especially the striatum, leading to the formation of
huntingtin protein aggregates in the cytoplasm [13]. Somatic
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sporadic Alzheimer patient who exhibited somatic mosaicism for
the mutation in peripheral lymphocytes and cerebral cortex [11].
We hypothesize that the octarepeat region of the human PRNP
gene is unstable in somatic cells, and that somatic octarepeat
mutations accumulate in long-living neurons and/or other cells in
the brain during development and/or aging, which may result in
spontaneous de novo formation of infectious prions in some brain
cells containing mutated octarepeats to initiate sCJD. The highly
heterogeneous phenotypes associated with familial octarepeat
mutations [1] could explain the diversity of sCJD. Here we report
that the human PRNP octarepeat sequence is unstable during PCR
amplification in vitro or DNA replication in E.coli and that DNA
mismatch repair deficiency leads to higher rates of octarepeat
mutation in E.coli. These findings are consistent with a somatic
octarepeat mutation-based etiology for sCJD in humans.
Results
Mutation of the octarepeats during PCR amplification
The wild type octarepeat region of human PRNP was cloned by
PCR amplification from a subject with a wild type PRNP gene
(Figure 1B). The wild type PrP ORF was amplified with Taq
polymerase and primers 42F and 45R to obtain a PCR fragment
that contained 232 bp of 59 non-coding sequence, the wild type
PrP ORF (762 bp) and 271 bp of 39 non-coding sequence, which
Figure 1. Human PRNP octarepeat sequences and cloned octarepeats for instability analysis. (A) Wild type and mutant human octarepeat
sequences. In the mutant octarepeats, the mutated bases are in bold case and underlined. R14 could be a chimera repeat between R1 and R4; R1a
could be a chimera repeat between R1 and R3; R2a could be a chimera between R2 and R3. The repeats in pOct5, pOct11a and pOct11b are listed. (B)
Diagram of cloned wild type human PRNP octarepeats used for instability analysis. PrP-Oct5: a region encompassing the wild type PrP ORF (762 bp),
232 bp upstream non-coding sequence and 271 bp downstream non-coding sequence subcloned into pGEM-T after PCR amplification (template: wt
human genomic DNA, primers: 42F and 45R). pOct5: the wild type octarepeat region subcloned into pGEM-T after PCR amplification (template: PrP-
Oct5, primers: HP20 and HP306r). Arrows denote the primers. (C) Diagram of cloned insertion mutant human PRNP octarepeats used for instability
analysis. PrP-Oct11a or PrP-Oct11b: a region encompassing an 11-repeat mutant PrP ORF (906 bp), 232 bp upstream non-coding sequence and
271 bp downstream non-coding sequence subcloned into pGEM-T after PCR amplification (template: one of two human genomic DNA samples
containing different 11-repeat octarepeats, primers: 42F and 45R). pOct11a or pOct11b: the 11-repeat octarepeat region subcloned into pGEM-T after
PCR amplification (template: PrP-Oct11a or PrP-11b, primers: HP20 and HP306r). Arrows denote the primers.
doi:10.1371/journal.pone.0026635.g001
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Oct5. Similarly, two 11-repeat mutant PrP ORFs were PCR
amplified from two subjects with different 11-repeat octarepeats,
which were then cloned into pGEM-T to obtain PrP-Oct11a and
PrP-Oct11b (Figure 1C). Sequencing of DNA isolated from single
colonies indicated that the PrP-Oct5 clone contained the wild type
R1-R2-R2-R3-R4 octarepeats, the PrP-Oct11a clone contained
the R1-(R2)
7-R3g-R3-R4 octarepeats and the PrP-Oct11b clone
contained the R1-(R2)
8-R3-R4 octarepeats (Figure 1A).
The instability of the octarepeat region during PCR amplifica-
tion was evaluated by determining the percentage of mutant
molecules in the PCR products (Figure 2A). First, the octarepeat
region was amplified from the cloned PrP-Oct5 or PrP-Oct11a as
templates using Taq polymerase and primers HP20 and HP306r.
Analysis of the PCR products on a 2% agarose gel demonstrated a
single clean band of expected size [308 bp for PrP-Oct5 and
452 bp for PrP-Oct11a, consisting of 131 bp upstream of the
octarepeats, the Oct5 (123 bp) or Oct11a (267 bp) octarepeats,
and 54 bp downstream of the octarepeats], confirming the
specificity of the PCR reactions (Figure 3A). Second, the PCR
products, which contained molecules with either the wild type
(input) octarepeats or mutant octarepeats due to PCR errors
(termed PCR-mutant), were cloned and analyzed to determine the
percentage of PCR-mutant molecules in the PCR products
(Figure 2A). An aliquot of the PCR product was ligated into the
pGEM-T vector and transformed into DH5a competent cells.
After direct colony screening by PCR, the colonies that contained
non-input octarepeats were cultured and plasmid DNAs were
extracted and analyzed by SpeI and SacII digestions to release the
octarepeat insert(s). This analysis revealed that, for PCR products
of PrP-Oct5, 6 out of 750 (0.8%) colonies contained mutant
octarepeats (Figure 3B, Table 1). Sequencing confirmed that these
colonies contained mutant octarepeats with various numbers of
repeats (Figure 3B). One was an insertion mutant with 6 repeats
(R1-R2-R2-R2-R3-R4). The other five were deletion mutants with
1–3 repeats, including two with 3-repeats of different sequences
(R1-R2a-R4 and R1-R3-R4), one with 2-repeats (R1a-R4), and
two with 1-repeat of different sequences (R4 and R14) (Figure 3B).
Mutant repeat units (R14, R1a and R2a) were found in three
mutant clones (for sequences see Figure 1), possibly due to
homologous recombination between repeats as previously pro-
posed [3].
PCR products of PrP-Oct11a produced 15 out of 147 (10.2%)
colonies with mutant octarepeats (Figure 3C, Table 1). All 15
mutant clones were deletion mutants containing 2–10 repeats,
with one clone each of 9 and 10 repeats [R1-(R2)
5-R3g-R3-R4
and R1-(R2)
6-R3g-R3-R4], 2 clones with a 6-repeats of the same
sequence (R1-R2-R2-R3g-R3-R4),3 clones with 5-repeats of two
sequences (R1-R2-R3g-R3-R4 and R1-R2-R2-R3-R4), 2 clones
with 4-repeats of different sequences (R1-R2-R3-R4 and R1-R3g-
R2-R4), 2 clones with 3-repeats of different sequences (R1-R2-R4
and R1-R3-R4), and 4 clones with 2-repeats of 3 different
sequences (R1-R4, R1a-R4, R1a-R14).
In addition, 1 out of 750 clones (0.13%) derived from PrP-Oct5
PCR products produced two fragments upon restriction digestion
with SacII and SpeI; one fragment was the same as the template
Oct5 octarepeats (R1-R2-R2-R3-R4) whereas the other was a
deletion mutant (R1a-R4) (Figure 3D). Further transformation
with this clone did not lead to separation of the two fragments and
digestion with a single-cut restriction enzyme produced two bands
instead of the single band expected for plasmid monomers,
indicating that this mutant clone is a plasmid dimer containing a
wild type Oct5 insert and a deletion insert, which is referred to as a
mutant dimer (Figure 2A). Similarly, 10 out of 147 clones (6.8%)
derived from PrP-OCT11a PCR products were mutant dimers
(Figure 3E), of which one was an insertion mutant [R1-(R2)
9-R3g-
R3-R4] and nine were deletion mutants, the latter including one
9-repeat mutant [R1-(R2)
5-R3g-R3-R4], seven 6-repeat mutants
with three different sequences [R1-(R2)
2-R3g-R3-R4, R1-(R2)
3-
R3-R4, and R1-(R2)
2-R3g-R3-R4c] (see the sequence of R4c
in Figure 1A), and one 5-repeat mutant [R1-(R2)
3-R3-R4]
(Figure 3E). Further examination of non-mutant colonies showed
that 2 out of 30 (6.7%) contained wild type plasmid dimers for
PCR products of PrP-Oct5 while 19 out of 30 (63.3%) contained
wild type plasmid dimers for PCR products of PrP-Oct11a,
indicating that the majority of colonies with plasmid dimers
contained only wild type (input) octarepeats as expected. In
contrast, the empty pGEM-T vector by itself failed to produce
detectable plasmid dimers, indicating that the presence of the
octarepeat inserts is critical for promoting dimer formation and
Oct11 is more effective in causing dimer formation than Oct5.
The observation that mutant colonies contained only mutant
plasmid dimers suggests that the mutant plasmid dimers were
initially formed during the ligation reaction (Figure 2A) through an
unknown mechanism. One possibility is that some ‘‘paired’’
molecules are formed via interactions between the octarepeat
regions of a wild type (input) molecule and a wild type or PCR-
mutant molecule during the PCR reactions, then ligation of two
pGEM-T plasmid vector molecules to one ‘‘paired’’ molecules
during the ligation reaction results in a plasmid dimer. Such inter-
molecule interactions could be enhanced by the repeated
denaturation, renaturation, and DNA replication cycles of the
PCR reaction and by the high concentrations of the PCR product
molecules in the later cycles of the PCR reaction. If, instead, the
mutant plasmid dimers were formed during replication in E.coli,
then most colonies with mutant plasmid dimers should contain a
larger amount of the original plasmid. Following transformation
each colony starts from a single cell containing a single plasmid
molecule and, with the low mutation rate in E.coli, mutation
during replication will most often occur in later rounds of plasmid
replication, making the mutant plasmid a minority of the final
plasmid DNA pool in the resulting colony. Therefore, the actual
total PCR mutation rate should be the sum of monomer mutants
and dimer mutants, which is 7 out of 750 (0.9%) for the PrP-Oct5
template and 25 out of 147 (17.0%) for the PrP-Oct11a template.
These results indicate that the Taq PCR mutation rate for PrP-
Oct11a is more than 18 times that of the wild type PrP-Oct5
template.
PCR products of PrP-Oct5 and PrP-Oct11a produced by the
high fidelity Pwo polymerase were also similarly examined
(Figure 4). PCR products of PrP-Oct5 produced 6 out of 882
(0.7%) colonies with mutant octarepeats of various repeat numbers
(Table 1; Figure 4B). All six were deletion mutants with 1–2
repeats, including four with a 2-repeat (R1-R4), and two with 1-
repeat of different sequences (R14 and R4) (Figure 4B). PCR
products from the PrP-Oct11a template produced18 out of 301
(6.0%) colonies with mutant octarepeats (Figure 4C, Table 1). All
18 mutant clones were deletion mutants containing 2–9 octar-
epeats, including two clones with a 9-repeat of the same sequence
[R1-(R2)
5-R3g-R3-R4], 2 clones with a 7-repeat of different
sequence [R1-(R2)
3-R3g-R3-R4 and R1-(R2)
5-R4], 1 clone with a
6-repeat (R1-R2-R2-R3g-R3-R4), 2 clones with a 5-repeat of the
same sequence (R1-R2-R3g-R3-R4), 2 clones with a 4-repeat of
different sequences (R1-R2-R3-R4 and R1-R3g-R3-R4), 3 clones
with a 3-repeat of two different sequences (1 of R1-R2-R4, 2 of
R1-R3-R4), and 6 clones with a 2-repeat of 2 different sequences
(5 of R1-R4, 1 of R1a-R14) (Figure 4C). Rare clones containing
mutant plasmid dimers were also found: 1 out of 882 clones from
Human Prion Protein Gene Octarepeat Instability
PLoS ONE | www.plosone.org 3 October 2011 | Volume 6 | Issue 10 | e26635the PrP-Oct5 template contained Oct5 and R1-R2 (Figure 4D)
while 3 out of 301 clones from the PrP-Oct11a template contained
Oct11a and either R1-(R2)
6-R3g-R3-R4 (2 clones) or R1-R2-R3g-
R3-R4 (1 clone) (Figure 4E). Thus, the total Pwo PCR mutation
rate is 0.8% (7 out of 882) for the PrP-Oct5 template and 7.0% (21
out of 301) for the PrP-Oct11a template.
Figure 2. Schematic diagrams for analysis of octarepeat mutation rate during PCR or replication in E.coli. (A) Measurement of
octarepeat mutants resulting from PCR amplification of octarepeats. Cloned PrP ORF sequences (PrP-Oct5 and PrP-Oct11a) were subjected to PCR
with primers HP20 and HP306r. The PCR products (depicted in a shaded box), which contained input (green line) and PCR-mutant (red line)
octarepeat sequences as well as ‘‘paired’’ molecules (two parallel lines), were cleaned up and ligated to the pGEM-T vector, producing 4 kinds of
ligation products: mutant monomer, wild type monomer, wild type dimer, and mutant dimer. The ligation products were transformed into DH5a
competent cells, and the resulting colonies were directly examined by PCR with primers HP50f and HP293r. Plasmid DNAs were extracted from
colonies containing mutant octarepeats, subjected to restriction analysis with SacII and SpeI, and sequenced. The number of mutant colonies over the
total number of colonies screened was calculated to represent the octarepeat mutation rate during the PCR process. Small oval: individual E.coli cell;
big dashed-line oval: E.coli colony. (B) Measurement of octarepeat mutants resulting from DNA replication in E.coli. pOct5 or pOct11b was used to
transform competent DH5a or XL-1 Red E.coli cells, and plasmid DNA sample prepared from a single colony (depicted in a shaded box) was used to
transform competent DH5a cells. The mutant colonies (containing only mutant plasmid, red dashed-line oval) and new mutant colonies [containing
some cells with the NEW replication-mutant octarepeat insert (light purple), light blue dashed-line oval] were screened out as in (A). The number of
mutant colonies (excluding the new mutant colonies) over the total number of colonies examined should reflect the octarepeat mutation rate during
the 1
st round of plasmid replication and cell division in E.coli (DH5a or XL-1 Red).
doi:10.1371/journal.pone.0026635.g002
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PLoS ONE | www.plosone.org 4 October 2011 | Volume 6 | Issue 10 | e26635Figure 3. Instability of octarepeats during PCR amplification by Taq Polymerase. (A) PCR products from the PrP-Oct5 and PrP-Oct11a
templates. The octarepeat regions PCR amplified by Taq polymerase from PrP-Oct5 and PrP-Oct11a with primers HP20 and HP306r were cleaned up
and separated on a 2% agarose gel. (B) Mutant octarepeat clones from PCR amplification of the PrP-Oct5 template: restriction analysis with SacII and
SpeI. Six mutant clones and one wild type clone are shown. The black box marks the template-sized Oct5 band from a wild type clone. (C) Mutant
octarepeat clones from PCR amplification of the PrP-Oct11a template: restriction analysis with SacII and SpeI. Same as in (B) except that PrPOct11a
Human Prion Protein Gene Octarepeat Instability
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Pwo octarepeat mutation rate is similar for the wild type human
octarepeats Oct5 (0.8% vs 0.9%) but moderately lower for the
insertion mutant Oct11a (7.0% vs 17.0%) (Table 1), indicating
that the fidelity of the polymerase used has only limited influence
on the PCR mutation rate of the octarepeat regions.
Mutation of the octarepeat regions during DNA
replication in DH5a E.coli cells
The instability of the octarepeat region was further evaluated
during DNA replication in vivo in DH5a, a popular E.coli strain for
molecular cloning procedures, which contains the recA1 mutation
that results in enhanced insert stability and the endA1 mutation
that leads to improved plasmid quality and yield.
First, the octarepeat regions in PrP-Oct5 and PrP-Oct11b were
amplified by PCR with primers HP20 and HP306r and subcloned
into the pGEM-T vector and sequenced to obtain pOct5 and
pOct11b (Figure 1B-C). The cloned pOct5 plasmid was used to
transform competent DH5a cells, and 3 plasmid DNA samples
were prepared, each from a single colony. Similarly, 3 plasmid
DNA samples were prepared from pOct11b transformed DH5a.
These plasmid DNA samples contained two types of plasmid
molecules: those with just the original octarepeats and those with
both the original octarepeats and mutant octarepeats resulting
from DNA replication errors in E.coli (termed replication-mutant)
(Figure 2B). Next, these plasmid DNA samples were used to
transform competent DH5a cells. After direct colony PCR scre-
ening, colonies with replication-mutant octarepeats were picked
for restriction analysis with SacII and SpeI and sequencing. The
percentage of replication-mutant plasmid molecules in the original
plasmid samples was determined by counting the number of
colonies containing replication-mutant octarepeats over the total
number of colonies screened (Figure 2B), which serves as a
measure of octarepeat mutation rate during DNA replication in
DH5a.
For pOct5, of the 4234 colonies screened, only 3 (0.07%)
contained replication-mutant octarepeats (Table 1). The three
replication-mutant octarepeats were all different: one was an
insertion mutant of 6-repeats [R1-(R2)
3-R3-R4] while the other
two were deletion mutants of different 4-repeat sequences (R1-R2-
R2-R4 and R1-R2-R3-R4) (Figure 5A). Interestingly, all three
colonies with replication-mutant octarepeats contained plasmids
that produced two octarepeat insert bands after digestion with
SacII and SpeI (Figure 5A); sequencing revealed that one of the two
insert bands contained the parental Oct5 octarepeats while the
other harbored the replication-mutant octarepeats. Further
transformation into DH5a with the three clones and restriction
analysis confirmed that these clones were all plasmid dimers.
Table 1. Mutation rate of octarepeats during PCR or DNA replication in E.coli.
Mutation Rate (%)
a
Input Amplification Prep 1
b Prep 2
b Prep 3
b Total
PrP-Oct5 PCR (Taq) NA NA NA 6/750 (0.8%)-monomer
1/750 (0.1%)-dimer
7/750 (0.9%)-all
PrP-Oct11a PCR (Taq) NA NA NA 15/147 (10.2%)-monomer
10/147 (6.8%)-dimer
25/147 (17%)-all
PrP-Oct5 PCR (Pwo) NA NA NA 6/882 (0.7%)-monomer
1/882 (0.1%)-dimer
7/882 (0.8%)-all
PrP-Oct11a PCR (Pwo) NA NA NA 18/301 (6.0%)-monomer
3/301 (1.0%)-dimer
21/301 (7.0%)-all
pOct5 DH5a 1/1717 1/1347 1/1160 3/4234 (0.07%)
pOct11b DH5a 1/104 2/108 1/104 4/316 (1.3%)
pOct5 XL1-Red 1/160 2/152 1/160 4/472 (0.8%)
pOct11b XL1-Red 1/32 1/40 2/60 4/132 (3.0%)
aNumber of colonies with mutant octarepeats/total colonies screened; percentage in the parenthesis.
bEach of the three plasmid preparations was made from a single E.coli colony.
doi:10.1371/journal.pone.0026635.t001
was the template. Fifteen mutant clones and one wild type clone are shown. The black box marks the template-sized Oct11 band from a non-mutant
clone. (D) A mutant octarepeat clone containing two octarepeat inserts from PCR amplification of PrP-Oct5. SacII and SpeI digestion of this mutant
clone produced two octarepeat inserts; one was the 5-repeat wild type Oct5 while the other was a 2-repeat deletion mutant (R1a-R4). The arrowhead
points to the band whose sequence is shown above the lane. The black box marks the template-sized Oct5 band from a non-mutant clone. (E)
Mutant octarepeat clones containing two octarepeat inserts from PCR amplification of PrP-Oct11a. SacII and SpeI digestion of the 10 mutant clones
produced two octarepeat inserts; one was the 11-repeat parental Oct11a in all clones while the other was a mutant octarepeat sequence of varying
sizes and sequences. The arrowhead points to the band whose sequence is shown above the lane. The black box marks the template-sized Oct11
band from a non-mutant clone. For all panels, the octarepeat sequence is indicated above each lane; Rep. No., number of repeats; M,100-bp DNA
Ladder.
doi:10.1371/journal.pone.0026635.g003
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PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e26635Figure 4. Instability of octarepeats during PCR amplification by Pwo polymerase. (A) PCR products from the PrP-Oct5 and PrP-Oct11a
templates. The octarepeat regions PCR amplified by Pwo polymerase from PrP-Oct5 and PrP-Oct11a with primers HP20 and HP306r were cleaned up
and separated on a 2% agarose gel. Bl, blank control. (B) Mutant octarepeat clones from PCR amplification of the PrP-Oct5 template: restriction
analysis with SacII and SpeI. Six mutant clones and one wild type clone are shown. The black box marks the template-sized Oct5 band from a non-
mutant clone. (C) Mutant octarepeat clones from PCR amplification of the PrP-Oct11a template: restriction analysis with SacII and SpeI. Same as in (B)
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contained replication-mutant octarepeats, indicating a mutation
rate that is 18 times higher than that of pOct5 in DH5a (Table 1).
All were deletion mutants, with one 8-repeat [R1-(R2)
5-R3-R4],
one 9-repeat [R1-(R2)
6-R3-R4] and two identical 10-repeat [R1-
(R2)
7-R3-R4] regions (Figure 5B). Again, all mutant plasmid
DNAs were dimers that produced the parental Oct11 band in
addition to the mutant octarepeat band (Figure 5B). There were
also two colonies containing mixed plasmid DNAs that produced a
strong Oct11 band plus 1–2 weaker mutant octarepeat bands
(Figure 5C). Re-transformation of plasmid DNAs from these two
colonies into DH5a led to two kinds of colonies, with the majority
containing only pOct11b and a minority containing plasmids with
just the newly generated mutant octarepeats. Sequencing con-
firmed that one of the two colonies contained two types of mutant
plasmid DNAs, one had a 12-repeat [R1-(R2)
9-R3-R4] and the
other had a 3-repeat (R1-R3-R4); the other colony contained only
one type of mutant plasmid with a 12-repeat [R1-(R2)
9-R3-R4]
(Figure 5D). We termed the mutant octarepeats in colonies with
mixed plasmids ‘‘NEW replication-mutant’’ (Figure 2B) because
these mutants were likely due to de novo mutations that were not
present in the original plasmid DNA samples prepared after the
first round of plasmid replication and cell division in E.coli
(Figure 2B).
Defective DNA mismatch repair augments octarepeat
mutation in E.coli cells
DNA mismatch repair is involved in correcting DNA mutations,
and aging leads to compromised DNA repair that may underlie
many age-related diseases [14–22]. To assess the influence of DNA
mismatch repair on octarepeat mutations, the mutation rates of
pOct5 and pOct11b were examined in XL-1 Red E.coli cells,
which have no functional mismatch repair genes since all three
primary mismatch repair genes (mutS, mutD, mutT) are defective.
The same protocol used to analyze octarepeat mutation in
DH5a cells was applied to pOct5 and pOct11b plasmid DNA
samples prepared from XL-1 Red E.coli cells (Figure 2B).
Plasmid DNAs were prepared from single colonies after
transformation of competent XL-1 Red cells with pOct5 or
pOct11b. After restriction analysis with SacII and SpeI, single-
colony plasmid DNA minipreps from XL-1 Red, three each for
pOct5 and pOct11b that showed no visible non-parental
octarepeat band, were selected as the input plasmid DNA
preparations for further transformation in DH5a cells to measure
the percentage of octarepeat mutants after propagation of pOct5
and pOct11b in XL-1 Red cells. This pre-selection of plasmid
DNA preparations from XL-1 Red cells is important because
plasmid DNA preparations that produced a visible mutant (non-
input) octarepeat band(s) would lead to an overestimate of the
mutation rate. For pOct5, of the 472 DH5a colonies screened,
only 4 (0.8%) contained mutant octarepeats (Table 1), including
two distinct insertion mutants with a 6-repeat [R1-(R2)
3- R3-R4
and R1-R2-R2-R3-R2a-R4] and two deletion mutants with a 4-
repeat (R1-R2-R3-R4) and a 2-repeat (R1-R4), respectively
(Figure 6A). For pOct11b, of the 132 DH5a colonies screened,
4 (3.0%) contained mutant octarepeats (Table 1). The four mutant
octarepeats were all deletion mutants, including two identical 10-
repeats [R1-(R2)
7-R3-R4] and two identical 8-repeats [R1-(R2)
5-
R3-R4] (Figure 6B). In addition, similar to the findings for DH5a-
replicated pOct11b, 2 of the 132 colonies from XL-1 Red-
replicated pOct11b contained NEW replication-mutant plasmid
dimers that produced the parental Oct11 band plus 1-2 weaker
mutant octarepeat bands upon digestion with SpeI and SacII
(Figure 6C). Subsequent separation by further transformation in
DH5a cells and sequencing confirmed that each of the weaker
mutant octarepeat band represented a plasmid dimer species
containing the parental Oct11b insert plus a mutant octarepeat
insert, the latter includes a 3-repeat (R1-R3-R4), a 7-repeat [R1-
(R2)
4-R3-R4] and an 8-repeat [R1-(R2)
5-R3-R4] (Figure 6D).
The octarepeat mutation rates are significantly higher in XL-1
Red cells than in DH5a cells for pOct5 (0.8% vs. 0.07%, p=0.003
by Fisher’s exact test), but the difference for pOct11b is not
statistically significant (3.0% vs. 1.3%, p=0.183 by Fisher’s exact
test). These results indicate that defective mismatch repair could
dramatically increase the mutation rate for the wild type Oct5
octarepeats.
Replication-mutant plasmids are all head-to-head dimers
After propagation of pOct5 and pOct11b in DH5a or XL-1
Red cells, all resulting mutant plasmids were plasmid dimers
containing the parental octarepeats plus a mutant octarepeat
sequence (Figures 5–6). To dissect the structures of these plasmid
dimers, plasmid DNAs were prepared from two mutant colonies
(containing only mutant plasmid dimer) and two control colonies
(containing only wild type plasmid monomer) after transformation
of pOct5 into DH5a, digested with SacII, SpeI, or ScaI, and
subjected to agarose gel electrophoresis (Figure 7A). Two mutant
plasmid samples derived from replication of pOct11b in DH5a
were similarly examined (Figure 7A). Upon ScaI digestion, the
control plasmids produced a single band with the expected size
corresponding to a monomer (lanes 9, 10 and 17, 18 in Figure 7A),
whereas the mutant plasmids produced two bands whose
combined size equals to a dimer (lanes 7, 8 and 15, 16 in
Figure 7A). PCR analysis of the DNA recovered from these two
bands revealed that the smaller band contained the parental
octarepeats while the bigger band contained the mutant
octarepeats. Upon SacII digestion, the mutant plasmids produced
two bands (lanes 5, 6 and 13, 14 in Figure 7A); the smaller band
(,0.4–0.5 kb) corresponds to the parental octarepeat insert while
the larger band (,6 kb) corresponds to the plasmid dimer
backbone containing the mutant octarepeat insert. Upon SpeI
digestion, the mutant pOct11b and pOct5 plasmids also produced
two bands (lanes 3, 4 and 11, 12 in Figure 7A); the smaller band
(,0.3–0.4 kb) corresponds to the mutant octarepeat insert while
the larger band (,6 kb) corresponds to the plasmid dimer
backbone containing the parental octarepeat insert.
These results revealed that all the mutant plasmids were
head-to-head dimers where one monomer unit contained the
except that PrPOct11a was the template DNA. Eighteen mutant clones and one wild type clone are shown. The black box marks the template-sized
Oct11 band from a non-mutant clone. (D) A mutant octarepeat clone containing two octarepeat inserts from PCR amplification of PrP-Oct5. SacII and
SpeI digestion of this mutant plasmid clone produced two octarepeat inserts; one was the wild type Oct5 while the other was a 2-repeat deletion
mutant (R1-R2). The arrowhead points to the band whose sequence is shown above the lane. The black box marks the template-sized Oct5 band
from a non-mutant clone. (E) Mutant octarepeat clones containing two octarepeat inserts from PCR amplification of PrP-Oct11a. SacII and SpeI
digestion of the 3 mutant clones produced two octarepeat inserts; one was the 11-repeat parental Oct11a in all clones while the other was a mutant
octarepeat sequence of varying sizes and sequences. The arrowhead points to the band whose sequence is shown above the lane. The black box
marks the template-sized Oct11 band from a non-mutant clone. For all panels, the octarepeat sequence is indicated above each lane; Rep. No.,
number of repeats; M,100-bp DNA Ladder.
doi:10.1371/journal.pone.0026635.g004
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the replication-mutant octarepeats (Figure 7B). Examination of
mutant plasmid samples derived from replication of pOct5 and
pOct11b in XL-1 Red cells gave the same result (data not
shown).
Discussion
Little is known about the etiology of sCJD in humans. In the
present study, we showed that the wild type 5-repeat octarepeat
region (Oct5) in the human PRNP gene is unstable during PCR
amplifications with a mutate rate of 0.9%. The insertion mutant
Oct11a was more unstable with a mutation rate of 17.0% during
PCR, 18 times greater than that of Oct5 (Table 1). Mutation
analysis of Oct5 and Oct11b during DNA replication in wild type
E.coli (DH5a) revealed octarepeat mutation rates of 0.07% and
1.3%, respectively. The spontaneous DNA mutation rate based on
the frequency of lacI mutants was 0.00013% in the wild type
NR9102 E.coli strain [23], which is more than 500 times lower
than the spontaneous octarepeat mutation rates we observed in the
Figure 5. Instability of octarepeats during DNA replication in DH5a cells. (A) Mutant clones from replication of pOct5 in DH5a cells. pOct5
was transformed into DH5a. Plasmid DNAs were prepared from the resulting colonies, digested with SacII and SpeI and separated on a 2% agarose
gel. Shown are plasmid DNAs from 3 colonies that produced two octarepeat bands of equal molar ratio. (B) Mutant clones from replication of
pOct11b in DH5a cells. pOct11b was transformed into DH5a. Plasmid DNAs were prepared from the resulting colonies, digested with SacII and SpeI
and separated on a 2% agarose gel. Shown are plasmid DNAs from 4 colonies that produced two octarepeat bands of equal molar ratio. (C–D)
Unusual mutant clones from replication of pOct11b in DH5a cells. Shown are plasmid DNAs from two pOct11b-transformed DH5a colonies that
produced 2–3 octarepeat bands upon digestion with SacII and SpeI, of which the template-sized band is much stronger than the mutant bands (C).
The unequal molar ratio of the octarepeat bands suggests the presence in these colonies of mixed plasmid DNA species where each species
produced one of the octarepeat bands. Re-transformation of these plasmid DNAs into DH5a cells resulted in separation of the mixed plasmid DNA
species and produced colonies that each contained only one plasmid DNA species as confirmed by restriction analysis and sequencing (D). For all
panels, the octarepeat sequence is indicated above each lane, the arrowhead points to the band whose sequence is shown above the lane, and the
black box marks the template-sized Oct5 or Oct11 band from a non-mutant clone. Rep. No., number of repeats; M,100-bp DNA Ladder.
doi:10.1371/journal.pone.0026635.g005
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three major DNA mismatch repair genes were defective, Oct5 had
a mutation rate of 0.8%, 11 times higher than that in DH5a;
Oct11b had a mutation rate of 3.0%, which is also higher than the
1.3% mutation rate found in DH5a although the difference did
not reach statistical significance. These results demonstrate that
the human PrP octarepeat region is inherently unstable during
DNA replication, octarepeat insertion mutants are even less stable,
and the instability of octarepeats is exacerbated by compromised
mismatch repair. Given the established link of octarepeat
mutations to familial prion diseases [1,24], our data support an
octarepeat somatic mutation-based etiology for sCJD as follows:
the instability of the octarepeat region leads to accumulation of
somatic octarepeat mutations in brain cells during development
and aging, and the instability is augmented by compromised DNA
mismatch repair in aged cells; eventually some of the octarepeat
Figure 6. Instability of octarepeats during DNA replication in mismatch repair-deficient XL-1 Red cells. (A) Mutant clones from
replication of pOct5 in XL-1 Red E.coli cells. Plasmid DNA samples were prepared from XL-1 Red colonies after transformation with pOct5 and re-
transformed into DH5a cells. Plasmid DNAs from the resulting DH5a colonies were digested with SacII and SpeI and separated on a 2% agarose gel.
Shown are plasmid DNAs from 4 DH5a colonies that produced two octarepeat bands of equal molar ratio. (B) Mutant clones from replication of
pOct11b in XL-1 Red E.coli cells. Same as in (A) except that pOct11b was used. Shown are plasmid DNAs from 4 colonies that produced two
octarepeat bands of equal molar ratio. (C–D) Unusual mutant clones from replication of pOct11b in XL-1 Red E.coli cells. Shown are plasmid DNAs
from two pOct11b-transformed XL-1 Red colonies that produced 2–3 octarepeat bands upon digestion with SacII and SpeI, of which the template-
sized band is much stronger than the mutant bands (C). The unequal molar ratio of the octarepeat bands suggests the presence of mixed plasmid
DNA species in these colonies. Further transformation of these plasmid DNAs into DH5a cells resulted in separation of the mixed plasmid DNA
species and produced colonies that each contained only one of the plasmid DNA species as confirmed by restriction analysis and sequencing (D). For
all panels, the octarepeat sequence is indicated above each lane, the arrowhead points to the band whose sequence is shown above the lane, and
the black box marks the template-sized Oct5 or Oct11 band from a non-mutant clone. Rep. No., number of repeats; M,100-bp DNA Ladder.
doi:10.1371/journal.pone.0026635.g006
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formation and replication to initiate sCJD. The heterogeneous
phenotypes associated with various octarepeat mutations [1] could
explain the phenotypic diversity of sCJD. A large number of point
mutations in the PRNP coding region have also been linked to
familial prion diseases in humans [1]. Consequently, somatic point
mutation in non-repeat PRNP coding regions in human brain cells
could also be a potential cause for sCJD and needs to be examined
in the future. Other remaining questions include: 1) Are
octarepeat sequences from PrPs of other species also unstable? 2)
Do human octarepeat sequences promote higher mutation rates in
flanking regions? 3) Are other repeat sequences in non-PrP genes
unstable as well? These are all important areas for future
investigations.
Figure 7. Mutant plasmids from octarepeat replication in DH5a are all head-to-head dimers. (A) Restriction analysis of replication-mutant
plasmids with SpeI, SacII and ScaI. pOct5 or pOct11b were transformed into DH5a. Plasmid DNAs were prepared from two mutant colonies and two
control (non-mutant) colonies each for pOct5 and pOct11b, digested with SpeI, SacII or ScaI, and separated by agarose gel electrophoresis. All mutant
colonies appear to contain a minute amount of monomer plasmids. M1, 100-bp DNA ladder; M2, 1-kb DNA ladder. (B) Diagram of the head-to-head
plasmid dimers. The top panel depicts the parental plasmid monomer; the bottom panel depicts the dimer where the newly generated monomer
unit is highlighted in thicker lines. The boxes denote the octarepeat inserts.
doi:10.1371/journal.pone.0026635.g007
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used in experiments to measure the octarepeat PCR mutation
rate. However, the commonly cited fidelity rates for PCR
polymerases are based on measurement of point-mutation errors,
which may have very different mechanism from that of repeat
expansion or contraction. To evaluate the impact of the
polymerase fidelity on the PCR mutation rate of the octarepeat
regions, we repeated the PCR experiments with the high fidelity
Pwo polymerase (Figure 4), whose point mutation rate is 18-fold
lower than that of Taq polymerase (http://www.roche-applied-
science.com). Our results indicate that polymerase fidelity, as
assessed on point mutations, has very limited influence on the
mutation rate of the wild type human octarepeats (Table 1),
suggesting that the mechanism for repeat expansion and
contraction are indeed different from those of point mutations.
The mutation rate of the wild type octarepeat sequence is still
below 1% in both DH5a and XL-1 Red cells, which is consistent
with the rarity of sCJD. However, in theory, a single brain cell
containing a somatic octarepeat mutation could generate the first
prion seed, thereby initiating sCJD. Since there are billions of
neurons and glial cells in a human brain, even a mutation rate of
0.001% will translate into tens of thousands of braincells carrying an
octarepeat mutation. Nevertheless, the occurrence of sCJD is very
rarebecause spontaneous denovoprion conversion muststill be a rare
event in cells harboring somatic octarepeat mutation. Even in
familial octarepeat mutation cases in which all cells carry the
mutation there is a strong age-dependent component [1]. The
majority of mutations we observed in PCR and DNA replication in
E.coli were deletions rather than insertions, but octarepeat deletions
are less commonly associated with familial prion disease [1]. On one
hand, the observed dominance of deletions during PCR and DNA
replication inE.coliisconsistent with the rarity of sCJD. On the other
hand, it is important to note that the proportion of octarepeat
insertion mutantsinhumanbrainislikelymuchhigherthanwhatwe
observed in E.coli, because it has been reported that repeat
contraction due to deletion biases is common in bacteria while
eukaryotesgenerally experienceunbiased mutation ora bias towards
insertion or repeat expansion [25]. In addition, the highly increased
mutation rate for the octarepeat insertion mutants does not explain
sCJD, but it may underscore the fact that the wild type octarepeat
region in humans has only 5 repeat units.
Reports of somatic point mutations in presenilin 1 gene in a
case of sporadic early onset Alzheimer’s disease [11] and in the
PRNP gene in a sCJD case [26] suggest that somatic point
mutations in other coding positions in PRNP may also lead to
sCJD. The next challenge is to set up sensitive and reliable assays
for direct measurement of somatic mutation rates of octarepeats
in neurons and other brain cells from brain tissues of normal
individuals and sCJD subjects. It is worth noting that the
observed high rate of octarepeat mutation during PCR
amplification indicates that PCR should not be used to assess
octarepeat mutation levels in human genomic DNAs if the
mutation level is low. Indeed, probably all PCR-based data
showing low levels of mutation in any extensive repeat sequence
should be interpreted with caution. Fortunately, since all
octarepeat mutants resulting from plasmid DNA replication in
E.coli are distinct and reside only in head-to-head plasmid dimers
(Figure 7), E.coli can still be used to directly quantify low levels of
octarepeat mutants in a genomic DNA sample if there is no prior
PCR amplification.
Significantly, all mutant octarepeats resulting from plasmid
DNA replication in E.coli were contained in head-to-head plasmid
dimers. Cruciform-dumbbell structures (hairpins on both DNA
strands) have been proposed to facilitate head-to-head plasmid
dimer formation in E.coli, resulting from cleavage of the
cruciform structure followed by replication [27,28]. Analysis
with the mfold program (http://mfold.rna.albany.edu/?q=
mfold/DNA-Folding-Form) reveals that both DNA strands of
Oct5 and Oct 11 octarepeats can form multiple stable hairpin
structures even under PCR reaction conditions (Figure 8A).
These observations suggest that the octarepeat region tends to
form hairpin structures on one or both DNA strands during DNA
replication, DNA repair or transcription. The hairpin structures
in turn promote mutation of the octarepeats through a
mechanism like DNA polymerase slippage [29] (Figure 8B), and
mismatch repair proteins play a significant role in the mutation
process. In addition, aging is known to contribute to somatic
mutations [30–33]. One major mechanism for age-related
somatic mutations is erroneous DNA repair after DNA damages
in aged cells [19,31]. In aged human brains, compromise of the
mismatch repair system may further enhance octarepeat
mutation and increase the chances of spontaneous de novo
formation of sCJD prions; the de novo prion agents may then
spread to surrounding cells initiating sCJD.
The PrP octarepeat region has significant biological functions.
The octapeptide repeats bind copper [34–38] and other divalent
cations such as zinc [39] in a pH-sensitive manner, and copper
and iron metabolism is abnormal in PrP-null or prion infected
mice [40–43]. The octapeptide repeat region is also crucial for
metal ion-induced endocytosis of the prion protein [44,45],
prevention of Purkinje cell death in a transgenic mouse model
[46], and PrP-mediated inhibition of Bax-induced cell death in
human primary neurons [47]. Some reports have shed light on
how octarepeat mutations may cause genetic prion diseases in
humans. PrP with expanded octarepeats due to insertion
mutations were more prone to aggregate and the extent of
aggregation was proportional to the number of repeats [48–50].
The size of the octarepeat region also affects PrP conversion by
PrP
Sc [51–53]. The increased propensity towards aggregation of
PrP with expanded octarepeats may underlie inherited prion
diseases caused by mutations of the octarepeat region. Moreover,
brain homogenates from human subjects with 5, 7 or 8 extra
octapeptide repeats transmitted the disease to non-human
primates [3,54]. However, the transmissibility of the nine
octapeptide repeat insertion mutant has not been tested and a
transgenic mouse model expressing mouse PrP with a 14-repeat
octarepeat region developed spontaneous, but non-transmissible,
neurodegenerative disease [55,56].
Tandem repeats, including microsatellites (simple tandem
repeats of 2–8 nucleotides) and minisatellites (variable number of
tandem repeats of usually 7–100 nucleotides that span 500–
20,000 bp) are common in eukaryotic genes and promoters [57]
and they mutate at high frequencies in both germ-line cells and
somatic cells [30,32,58–61]. Intergenerational and somatic
instability of repeat sequences has been convincingly associated
with neurodegenerative diseases. Over 20 unstable microsatellite
repeats consisting of repeats of 3–5 nucleotides have been linked to
neurological diseases, including the CGG repeats in the FMR1
gene for fragile X syndrome, the CAG repeats in the androgen
receptor for Kennedy’s disease, the CAG repeats in the huntingtin
gene for Huntington’s disease (HD), the CTG repeats in the
DMPK gene for myotonic dystrophy type 1, the CCTG repeats
in the ZNF9 gene for myotonic dystrophy type 2, and the ATTCT
repeats in the ATXN10 gene for spinocerebellar ataxia type
10 [62] . Many of the microsatellite repeats exhibit significant
tissue-specific somatic instability. The CTG repeat in the DMPK
gene of myotonic dystrophy type 1 patients is highly unstable in
muscle cells [63,64]. The CAG repeat region in the huntingtin
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[8–10]. Moreover, the CAG repeat expansion in HD brains was
reported to occur prior to clinical disease onset and become more
pronounced over time [12]. The longer the repeat length of the
somatically expanded CAG repeats, the earlier the age of disease
onset [65]. In general, longer repeats are associated with more
severe instability, which was confirmed in transgenic mouse
models expressing CTG repeats of various lengths [66]. Germ-line
and somatic minisatellite instability is also common in the human
genome [58,59,67,68]. The instability of the PRNP octarepeat
region, which does not qualify as a minisatellite due to its limited
size and contains mostly imperfect tandem repeats, suggests that
somatic instability of less dramatic tandem repeats in functional
genes may be more common than thought and their potential
relationship to development of sporadic diseases should be
examined more closely.
Materials and Methods
Ethics statement
The human brain tissue samples were obtained from the National
Prion Disease Pathology Surveillance Center at Case Western Reserve
University, Ohio. All samples are from deceased subjects, and personal
information is limited to age, sex, symptoms, neuropathology, and
classification of prion disease. These samples have been classified as
‘‘not human subjects’’ by the University Hospitals Case Medical
Center Institutional Review Board since our research meets criteria for
exemption under Federal regulations 45 CFR 46.102 (f).
Figure 8. A hairpin structure-based model for mutation of octarepeats. (A) Diagram of hairpin structures of Oct5 and Oct11b as predicted
by mfold. The likely secondary structures of Oct5 and Oct11b octarepeat sequences were examined with the online mfold program (http://mfold.rna.
albany.edu/?q=mfold/DNA-Folding-Form). Only the most stable structure for each sequence as predicted by mfold at the PCR annealing condition
(50 mM Na
+, 1.5 mM Mg
2+, 58.5uC) is depicted, but the E.coli condition (170 mM Na
+,3 7 uC) yielded similar results. The three colored hairpins
represent the common ones shared by Oct5 and Oct11b sequences; the insertion of 6 extra repeats in Oct11b led to 6 additional hairpins (in black)
that are identical to the first hairpin (in orange). (B) Hairpin-based slippage model for contraction or expansion of the octarepeats. The parental DNA
strands are in thick lines and the newly synthesized DNA strands (leading strand or lagging stand) are in thin lines. The red lines denote the
octarepeat region on parental DNA strands while green lines denote the octarepeat region on the newly synthesized DNA strands; hairpin formation
on the parental DNA strand leads to contraction whereas hairpin formation on the lagging strand being synthesized results in expansion. Adopted
from Figure 3 in [29].
doi:10.1371/journal.pone.0026635.g008
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Frozen human brain tissues were provided by the National
Prion Disease Pathology Surveillance Center at Case Western
Reserve University. Brain tissue (10–20 mg) was incubated at
55uC overnight in 560 ml of lysis buffer (50 mM Tris-Cl, 0.1 M
EDTA,1% SDS,100 mM NaCl, 400 mg/ml of proteinase K
(Roche, IN, USA), and genomic DNA was extracted using a
standard phenol/chloroform protocol, dissolved in water and
stored at220uC in multiple aliquots for further experiments.
Preparation of PCR templates (PrP-Oct5 and PrP-Oct11a)
and plasmids (pOct5, pOct11b) for mutation analysis
Genomic DNA from one subject with wild type PrP-129MM
was used to clone by PCR the wild type human PrP ORF
template, which is named PrP-Oct5 for the five-repeat octarepeats
(Figure 1B). Similarly, genomic DNAs from two subjects with PrP-
129MM and different 11-repeat mutant alleles were used to clone
by PCR the insertion mutant human PrP ORF templates, named
PrP-Oct11a and PrP-Oct11b, respectively (Figure 1C). The
human PrP ORF was amplified by PCR with a Mastercycler
thermal cycler (Eppendorf, NY, USA) in a 50 ml reaction
containing 50 ng human genomic DNA, 200 mM dNTPs (each),
1.5 mM MgCl2, 0.4 mM each of primers 42F (CATAACT-
TAGGGTCACATTTGTCC) and 45R (CCAGATTAACCAA-
TGGTTATTTGC), and 5 units of Taq DNA polymerase (Roche,
IN, USA). The PCR cycles were: 94uC for 2 min; 94uC for 30 sec,
58.5uC for 30 sec and 72uC for 90 sec for 31 cycles; 72uC for
7 min. All primers used in this study were HPLC-purified
(Invitrogen, CA, USA). The A260/280 ratios of DNA samples
in this study were 1.8–2.0 as assayed with a Nanovue
spectrophotometer (GE Healthcare, NJ, USA). The expected
PCR products were 1265 bp for PrP-Oct5 and 1409 bp for PrP-
Oct11a and PrP-Oct11b, which include 232 bp upstream of the
ATG initiation codon, the PrP ORF (762 bp for PrP-Oct5 and
906 bp for PrP-Oct11a/b), and 271 bp downstream of the stop
codon. The PCR amplified PrP ORFs were cloned into the
pGEM-T vector (Promega, WI, USA) (see below) and the
sequences confirmed by automated sequencing using primers
HP306f (GAGTAAGCCAAAAAC-CAACATG) and HP432r
(CGATAGTAACGGTCCTCATAG). The PrP-Oct5 clone had
the expected 5 wild type repeats (R1-R2-R2-R3-R4); the PrP-
Oct11a clone had R1-(R2)
7-R3g-R3-R4 and the PrP-Oct11b
clone had R1-(R2)
8-R3-R4 where (R2)
7 and (R2)
8 denote 7 and 8
consecutive R2 repeats, respectively (Figure 1A). Cloned PrP-Oct5
and PrP-Oct11a were used as the templates for PCR mutation
analysis. The octarepeat region of PrP-Oct5, PrP-Oct11a and PrP-
Oct11b were subcloned into pGEM-T after PCR amplification
with primers HP20 (GGATGCTGGTTCTCT-TTGTG) and
HP306r (CATGTTGGTTTTTGGCTTACTC) and confirmed
again by sequencing to obtain pOct5, pOct11a and pOct11b,
respectively (Figure 1B-C). pOct5 and pOct11b were used for
octarepeat mutation analysis in E.coli.
Mutation detection in PCR products or plasmid DNAs
replicated in E.coli
The octarepeat mutation rates in PCR products or plasmid
DNAs replicated in E.coli were measured as depicted in Figure 2.
To measure the mutation rate in the octarepeat region during
PCR amplification, the octarepeat region was amplified by PCR
from PrP-Oct5 or PrP-Oct11a with primers HP20 and HP306r
and either Taq polymerase (Roche, IN, USA) or Pwo polymerase
(Roche, IN, USA). The PCR products were treated with the
Wizard PCR clean-up kit (Promega, WI, USA), ligated to pGEM-
T (for Pwo-amplified products, A-tailing was done first with Taq
DNA polymerase in PCR buffer with 0.2 mM dATP) and
transformed into competent DH5a cells (New England Biolabs,
MA, USA) on LB-agar plates with X-gal. Direct colony PCR
screening was conducted as follows. Individual white and light
blue colonies were directly picked by pipette tips into 20 ml of PCR
reaction mix [200 mM dNTPs (each), 16PCR buffer containing
1.5 mM MgCl2, 0.4 mM each of primers, and 2 units of Taq DNA
polymerase] and subjected to PCR with primers HP50F
(GTGACCTGGGCCTCTGCAAG) and HP293R (CTTACT-
CGGCTTGTTCCACT) as follows: 94uC for 2 min; 94uC for 30
sec, 66.5uC for 30 sec and 72uC for 60 sec for 17 cycles; 72uC for
7 min. The PCR products were separated on 2% agarose gels
containing ethidium bromide. Sometimes bacteria picked from 2–5
colonies werepooled for one PCRreaction to increase the screening
throughput; if non-template sized band(s) was found for a pooled
sample, each of the 2–5 colonies was then picked separately and
plasmid DNA extracted and examined to determine the mutant-
containing colony. The mutant-containing colonies were grown
overnight in LBmedium,and plasmid DNAs were extractedusing a
plasmid DNA miniprep kit (Promega, WI, USA) and subjected to
double digestion with restriction enzymes SacII and SpeI (New
England Biolabs, MA, USA); the released octarepeat insert band(s)
was recovered and subjected to automated sequencing. The 100-bp
DNA ladder and 1-Kb DNA ladder (New England Biolabs, MA,
USA) wereused as markers for agarose gel electrophoresis.Colonies
that contained mutant (non-input) octarepeats were counted as
octarepeat mutants. The mutation rate was calculated as the
number of octarepeat mutant colonies over the total number of
colonies screened.
To measure the mutation rate of octarepeats during DNA
replication in wild type E.coli (DH5a), pOct5 or pOct11b was
transformed into DH5a. Plasmid DNA prepared from a single
DH5a colony from transformation with pOct5 or pOct11b was
used to as the input plasmid preparation. The input plasmid
preparation was transformed into DH5a, and the resulting
colonies were subjected to PCR screening. The colonies that
produced a mutant (non-input) octarepeat band(s) during the PCR
screen were subjected to overnight culture, plasmid DNA
extraction, restriction enzyme analysis and sequencing. The
mutation rate was calculated as the number of DH5a colonies
containing non-input octarepeats over the total number of DH5a
colonies screened. Three input pOct5 DNA preparations and
three input pOct11b preparations, each extracted from a single
DH5a colony, were examined in this fashion, and the average
mutation rate calculated (Table 1).
Similar protocol was applied to estimating the mutation rates of
Oct5 and Oct11b in the DNA repair-deficient XL-1 Red E.coli
cells (Stratagene, CA, USA). pOct5 or pOct11b plasmid DNA was
transformed into competent XL-1 Red cells. Plasmid DNA
minipreps were obtained from single XL-1 Red colony and
examined by restriction analysis with SacII and SpeI. Three
plasmid minipreps each for pOct5 and pOct11b that did not show
visible mutant (non-parental) octarepeat insert band on agarose
gels were selected as the input plasmid samples, which were used
for further transformation into DH5a and octarepeat mutant
screening as described above.
Sequencing and alignment
Plasmid DNAs and gel-purified PCR products or restriction
digestion fragments were subject to automated sequencing and the
resulting sequences were aligned with wild type human PrP sequence
using LALIGN (http://xylian.igh.cnrs.fr/bin/lalign-guess.cgi).
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Octarepeat sequences (Oct5 and Oct11) were subjected to
the online DNA mfold analysis (http://mfold.rna.albany.edu/?q=
mfold/DNA-Folding-Form) to predict potential secondary struc-
tures. The foldingparametersfor PCRconditions were50 mMNa
+
and 1.5 mM Mg
2+ at the three PCR temperatures: 94uC
(denaturation), 58.5uC (annealing), or 72uC (extension); the folding
parameters for E.coli were 170 mM Na
+ at 37uC.
Statistics analysis
Statistical significance was evaluated by Fisher’s exact test
(1-sided) with the SPSS 13.0 software (SPSS Int.).
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